Accuracy and Sustainability of SCALE-EYE Evaluation for Measuring Reliable Polyp Size
Recruiting
N/A
Interventional Study
Colorectal Polyps
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 55 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 241 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A multicenter, randomized, parallel group, endoscopist blinded study to assess the diagnostic performance and sustainability of SCALE-EYE in a screening and surveillance colonoscopy population. Sustainability will be evaluated in terms of the reduction in colonoscopies, associated waste and carbon footprint.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants aged 55-80
* Scheduled for fecal immunochemical test (FIT) screening or surveillance colonoscopy
* Polyps of all forms ≤25 mm as assessed by the endoscopist
Exclusion Criteria:
* No detected colorectal polyps or only diminutive (≤5 mm) hyperplastic rectal polyps…
Contacts
No contact information available.